Lupus Nephritis News, Treatment Studies | SLE, Renal Disorders Treatment

Lupus Nephritis

LUPUS NEPHRITIS

kidneys red

Obinutuzumab Gets Breakthrough Status for Treatment of Lupus Nephritis

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to obinutuzumab (Genentech), a CD20-directed cytolytic antibody, for the treatment of adults with lupus nephritis. The designation was based on data from the phase 2 NOBILITY study that compared the efficacy and safety of obinutuzumab, in combination with mycophenolate mofetil (MMF) or mycophenolic acid…
Next post in Lupus Nephritis